AuntMinnie.com staff writersNuclear MedicineITM opens Lu-177 production facilityITM Isotope Technologies Munich has opened a new manufacturing plant in Neufahrn, Germany, specifically designed to produce lutetium-177 (Lu-177) for use in cancer therapies.June 18, 2023Radiation Oncology/TherapyNorthStar appoints new president/CEONorthStar Medical Technologies, the parent company of NorthStar Medical Radioisotopes, has appointed Frank Scholz, PhD, as its new president and CEO.June 18, 2023Radiation Oncology/TherapyNavidea secures $7.5M from Cardinal HealthImmunodiagnostics and immunotherapy drug developer Navidea Biopharmaceuticals has secured $7.5 million from Cardinal Health in lieu of a milestone payment.June 18, 2023CTHHS and MARS collaborate on photon-counting spectral CT technologyNew York's Hospital for Special Surgery (HSS) and MARS Bioimaging have inked plans to collaborate on photon-counting spectral CT imaging technology.June 15, 2023Molecular ImagingGE touts first patient scanned in PET imaging trialGE HealthCare had its first patient scanned in a phase I clinical trial for an investigational F-18 CD8-targeted PET imaging radiopharmaceutical.June 15, 2023UltrasoundPhilips secures FDA clearance for Lumify B-mode featurePhilips has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an automated merged B-lines feature for its Lumify ultrasound system.June 14, 2023AIMedivis raises $20M in funding roundAugmented reality company Medivis is highlighting its $20 million series A funding round led by researchers, investors, and NBA superstar Kevin Durant.June 14, 2023Radiation Oncology/TherapyRaySearch signs agreement with ShinvaRaySearch Laboratories recently entered into an agreement with Shinva, a Chinese radiation therapy machine manufacturer.June 14, 2023Industry NewsCarestream touts tech displays at AHRA 2023Carestream Health will display new medical imaging technology at the upcoming American Healthcare Radiology Administrators (AHRA) 2023 meeting, the vendor said.June 14, 2023AIAvenda spotlights AI prostate cancer studyAI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.June 13, 2023Previous PagePage 24 of 3774Next PageTop StoriesMRIAdverse reaction rates to GBCAs are low in childrenThe review suggests gadolinium-based contrast agents (GBCAs) are relatively safe for children.AIInformatics leaders propose AI model integration frameworkWomens ImagingAI reduces false-negative rates on screening DBTMolecular ImagingVisual reads of amyloid PET scans effective in real-world settingsSponsor ContentYou think ahead. We innovate ahead.